Managed Care Cast

In this month's issue of The American Journal of Accountable Care®, a sister publication of The American Journal of Managed Care®, a commentary argues that current population health efforts under Medicare's Merit-based Incentive System (MIPS) have been hampered by the misalignment of accountability, and therefore, population health management will improve when shared accountability among stakeholders is achieved.

On March 7, The American Journal of Managed Care® will host its latest Institute for Value-Based Medicine in Dallas, Texas, with the Advancing Quality Oncology Care in the Evolving Value-Based Care Landscape meeting.

In this podcast, we speak with Rebecca Siegel, MPH, strategic director of surveillance information services in the Intramural Research Department at the American Cancer Society, and the lead author of the annual Cancer Statistics report that estimates the number of new cancer cases and deaths in the United States each year.

Five years ago, the American Cancer Society (ACS) recommended that patients at average risk of colorectal cancer start getting screened at age 50. However, in recent years, cancer incidence has changed, with a growing incidence seen in patients under age 50. Reflecting this change, ACS changed the recommended sceening age to 45 in May 2018.

Dori A. Cross, PhD, discusses a study she was an author on, which characterized the drivers of the use of electronic health information exchange by skilled nursing facilities to access patient hospital data during care transitions. The paper was published in the annual health information technology issue from The American Journal of Managed Care®.

As we enter an era of megamergers like the one between CVS Health and Aetna, The American Journal of Managed Care® convened its Oncology Stakeholder Summit to discuss the history of mergers and acquisitions, the reasons behind them, and what they mean for different stakeholders.

A study published in this month's issue of The American Journal of Managed Care® estimated standardized episode-level spending for patients across subcategories of care for each hospital referral region—defined by the Dartmouth Atlas—in order to identify the greatest opportunities for cost savings under the Oncology Care Model (OCM).

Who sets the price for medications and other supplies used in hospitals and why are there shortages of some of these items? Martin Makary, MD, MPH, a surgical oncologist and chief of the Johns Hopkins Islet Transplant Center as well as executive director of Choosing Wisely, discussed this issue and its ramifications for healthcare costs.


Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo